Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Peptide Synthesis Market Trends and Forecast
3.3: Global Peptide Synthesis Market by Product
3.3.1: Reagents
3.3.2: Equipment
3.3.2.1: Peptide Synthesizer
3.3.2.2: Chromatography Equipments
3.3.2.3: Lyophilizers
3.4: Global Peptide Synthesis Market by Technology
3.4.1: Solid-Phase Peptide Synthesis (SPPS)
3.4.2: Solution-Phase Synthesis (SPS)
3.4.3: Hybrid and Recombinant Technology
3.5: Global Peptide Synthesis Market by Application
3.5.1: Therapeutics
3.5.1.1: Cancer
3.5.1.2: Metabolic
3.5.1.3: Cardiovascular Disorder
3.5.1.4: Respiratory
3.5.1.5: GIT (Gastrointestinal Disorders)
3.5.1.6: Infectious Diseases
3.5.1.7: Pain, Dermatology
3.5.1.8: CNS (Central Nervous System)
3.5.1.9: Renal
3.5.1.10: Others
3.5.2: Diagnosis
3.5.3: Research
3.6: Global Peptide Synthesis Market by End User
3.6.1: Pharmaceutical & Biotechnology Companies
3.6.2: Contract Research Organizations (CROs)
3.6.3: Academic and Research Institutes
4. Market Trends and Forecast Analysis by Region
4.1: Global Peptide Synthesis Market by Region
4.2: North American Peptide Synthesis Market
4.2.1: Market by Product: Reagents and Equipment (Peptide Synthesizer, Chromatography Equipments, and Lyophilizers)
4.2.2: Market by Technology: SPPS, SPS, and Hybrid and Recombinant Technology
4.2.3: Market by Application: Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Infectious Diseases, Pain, Dermatology, CNS, Renal, and Others), Diagnosis, and Research
4.2.4: Market by End User: Pharmaceutical & Biotechnology Companies, CROs, and Academic and Research Institutes
4.2.5: The United States Peptide Synthesis Market
4.2.6: The Canadian Peptide Synthesis Market
4.2.7: The Mexican Peptide Synthesis Market
4.3: European Peptide Synthesis Market
4.3.1: Market by Product: Reagents and Equipment (Peptide Synthesizer, Chromatography Equipments, and Lyophilizers)
4.3.2: Market by Technology: SPPS, SPS, and Hybrid and Recombinant Technology
4.3.3: Market by Application: Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Infectious Diseases, Pain, Dermatology, CNS, Renal, and Others), Diagnosis, and Research
4.3.4: Market by End User: Pharmaceutical & Biotechnology Companies, CROs, and Academic and Research Institutes
4.3.5: The Peptide Synthesis Market of United Kingdom
4.3.6: The German Peptide Synthesis Market
4.3.7: The French Peptide Synthesis Market
4.4: APAC Peptide Synthesis Market
4.4.1: Market by Product: Reagents and Equipment (Peptide Synthesizer, Chromatography Equipments, and Lyophilizers)
4.4.2: Market by Technology: SPPS, SPS, and Hybrid and Recombinant Technology
4.4.3: Market by Application: Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Infectious Diseases, Pain, Dermatology, CNS, Renal, and Others), Diagnosis, and Research
4.4.4: Market by End User: Pharmaceutical & Biotechnology Companies, CROs, and Academic and Research Institutes
4.4.5: The Chinese Peptide Synthesis Market
4.4.6: The Indian Peptide Synthesis Market
4.4.7: The Japanese Peptide Synthesis Market
4.5: ROW Peptide Synthesis Market
4.5.1: Market by Product: Reagents and Equipment (Peptide Synthesizer, Chromatography Equipments, and Lyophilizers)
4.5.2: Market by Technology: SPPS, SPS, and Hybrid and Recombinant Technology
4.5.3: Market by Application: Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Infectious Diseases, Pain, Dermatology, CNS, Renal, and Others), Diagnosis, and Research
4.5.4: Market by End User: Pharmaceutical & Biotechnology Companies, CROs, and Academic and Research Institutes
4.5.5: Brazilian Peptide Synthesis Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Peptide Synthesis Market by Product
7.1.2: Growth Opportunities for the Global Peptide Synthesis Market by Technology
7.1.3: Growth Opportunities for the Global Peptide Synthesis Market by Application
7.1.4: Growth Opportunities for the Global Peptide Synthesis Market by End User
7.1.5: Growth Opportunities for the Global Peptide Synthesis Market by Region
7.2: Emerging Trends in the Global Peptide Synthesis Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Peptide Synthesis Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Peptide Synthesis Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: GenScript Biotech Corporation
8.2: AAPPTec
8.3: Bachem
8.4: AnaSpec
8.5: Biotage
8.6: CEM Corporation
8.7: Gyros Protein Technologies
8.8: Advanced ChemTech
8.9: New England Peptide, Inc.
8.10: Merck KGaA